Strontium ranelate incorporated 3D porous sulfonated PEEK simulating MC3T3-E1 cell differentiation

Current implant materials face limitations in promoting bone integration. PEEK, while mechanically suitable, lacks bioactive properties. This gap motivated the search for surface modifications that could enhance osseointegration. Prior research has shown that sulfonation improves material wettability. However, no prior work had resolved the challenge of combining drug loading with porous scaffold structures. The bioinert nature of PEEK limits its clinical utility in bone regeneration contexts. Strontium-based compounds have been known to influence bone cell behavior. This paper introduces a novel approach to address these limitations. The study aims to explore whether drug-loaded porous PEEK can improve cellular responses.

The goal was to evaluate a new method for enhancing PEEK's bioactivity through strontium ranelate incorporation. The specific problem is the poor osseointegration of standard PEEK implants. The motivation comes from the need for implants that support bone cell differentiation. The researchers propose that sulfonated PEEK with strontium ranelate could improve cell adhesion and mineralization. The approach involves modifying PEEK surfaces with a drug known to influence bone formation. The study focuses on the effects of strontium ranelate loading on cell behavior. The aim is to assess whether these modifications can lead to improved implant performance. The work seeks to provide a foundation for future implant material development.

The study used sulfonated three-dimensional PEEK structures as the base material. Strontium ranelate was applied at varying concentrations to the porous surfaces. Field-emission scanning electron microscopy was employed to analyze surface topography. X-ray photoelectron spectroscopy measured elemental composition, including carbon, oxygen, and strontium. Surface zeta potentials and water-contact angles were also assessed. The researchers evaluated cell adhesion and activity on the modified surfaces. MC3T3-E1 cells were used as a model for bone cell behavior. The methods focused on quantifying changes in cell function and material interaction.

Strontium ranelate was successfully loaded onto the sulfonated PEEK surfaces. Field-emission scanning electron microscopy confirmed structural integrity and drug distribution. X-ray photoelectron spectroscopy showed increased strontium content with higher drug concentrations. Surface zeta potentials and water-contact angles indicated improved wettability. MC3T3-E1 cell adhesion was significantly enhanced on the modified surfaces. Alkaline phosphatase activity increased by up to 30% compared to controls. Collagen secretion and extracellular matrix mineralization were also elevated. These findings suggest that SP-SR surfaces support enhanced osteoblast-like cell function.

The authors propose that SP-SR surfaces improve cell adhesion and function compared to untreated PEEK. The results suggest that strontium ranelate loading enhances the bioactivity of sulfonated PEEK. The study indicates that these modifications could lead to better osseointegration in implants. The findings align with prior knowledge about strontium's role in bone formation. The researchers did not claim the material is essential for all implant applications. The work highlights the potential of drug-loaded porous structures in implant design. The conclusions are limited to the observed effects on MC3T3-E1 cells in vitro. The authors suggest further in vivo testing to confirm clinical relevance.